These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31945303)

  • 81. Advancing translational research and precision medicine with targeted proteomics.
    Uzozie AC; Aebersold R
    J Proteomics; 2018 Oct; 189():1-10. PubMed ID: 29476807
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Acid ceramidase is upregulated in AML and represents a novel therapeutic target.
    Tan SF; Liu X; Fox TE; Barth BM; Sharma A; Turner SD; Awwad A; Dewey A; Doi K; Spitzer B; Shah MV; Morad SA; Desai D; Amin S; Zhu J; Liao J; Yun J; Kester M; Claxton DF; Wang HG; Cabot MC; Schuchman EH; Levine RL; Feith DJ; Loughran TP
    Oncotarget; 2016 Dec; 7(50):83208-83222. PubMed ID: 27825124
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia.
    Gamis AS; Alonzo TA; Perentesis JP; Meshinchi S;
    Pediatr Blood Cancer; 2013 Jun; 60(6):964-71. PubMed ID: 23255301
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Shining a light on cell signaling in leukemia through proteomics: relevance for the clinic.
    Hoff FW; Hu CW; Qutub AA; de Bont ESJM; Horton TM; Kornblau SM
    Expert Rev Proteomics; 2018 Jul; 15(7):613-622. PubMed ID: 29898608
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Reverse phase protein arrays in acute leukemia: investigative and methodological challenges.
    Hoff FW; Horton TM; Kornblau SM
    Expert Rev Proteomics; 2021 Dec; 18(12):1087-1097. PubMed ID: 34965151
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Proteomic approaches for untangling pharmacological targets in acute myelogenous leukemia.
    Reikvam H; Hemsing AL; Hernandez-Valladares M; Birkeland E
    Expert Rev Proteomics; 2022 Feb; 19(2):73-76. PubMed ID: 35436165
    [No Abstract]   [Full Text] [Related]  

  • 87. Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches.
    Dowling P; Tierney C; Dunphy K; Miettinen JJ; Heckman CA; Bazou D; O'Gorman P
    Proteomes; 2021 Oct; 9(4):. PubMed ID: 34842843
    [TBL] [Abstract][Full Text] [Related]  

  • 88. IDH1R132, IDH2R140 and IDH2R172 in AML: different genetic landscapes correlate with outcome and may influence targeted treatment strategies.
    Meggendorfer M; Cappelli LV; Walter W; Haferlach C; Kern W; Falini B; Haferlach T
    Leukemia; 2018 May; 32(5):1249-1253. PubMed ID: 29568090
    [No Abstract]   [Full Text] [Related]  

  • 89. Future perspective: metabolism as a therapeutic target in acute myeloid leukemia - from Warburg to precision medicine.
    Hatfield KJ; Grønningsaeter IS; Reikvam H
    Curr Med Res Opin; 2021 Dec; 37(12):2107-2111. PubMed ID: 34498983
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Targeting HIF-1 to treat AML.
    Flood D; Taylor CT
    Nat Cancer; 2024 Jun; 5(6):821-822. PubMed ID: 38937651
    [No Abstract]   [Full Text] [Related]  

  • 91. Acute Myeloid Leukemia: Historical Perspective and Progress in Research and Therapy Over 5 Decades.
    Kantarjian HM; Short NJ; Fathi AT; Marcucci G; Ravandi F; Tallman M; Wang ES; Wei AH
    Clin Lymphoma Myeloma Leuk; 2021 Sep; 21(9):580-597. PubMed ID: 34176779
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Proteomics-based prediction of clinical response in acute myeloid leukemia.
    Albitar M; Potts SJ; Giles FJ; O'Brien S; Jilani I; Donahue AC; Estey EH; Kantarjian H
    Exp Hematol; 2009 Jul; 37(7):784-90. PubMed ID: 19422784
    [TBL] [Abstract][Full Text] [Related]  

  • 93. HLX in AML: novel prognostic and therapeutic target.
    Pandolfi A; Steidl U
    Oncotarget; 2012 Oct; 3(10):1059-60. PubMed ID: 23888188
    [No Abstract]   [Full Text] [Related]  

  • 94. Global Proteomic Profiling of Pediatric AML: A Pilot Study.
    Nguyen NHK; Wu H; Tan H; Peng J; Rubnitz JE; Cao X; Pounds S; Lamba JK
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202615
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia.
    Zeng AGX; Bansal S; Jin L; Mitchell A; Chen WC; Abbas HA; Chan-Seng-Yue M; Voisin V; van Galen P; Tierens A; Cheok M; Preudhomme C; Dombret H; Daver N; Futreal PA; Minden MD; Kennedy JA; Wang JCY; Dick JE
    Nat Med; 2022 Jun; 28(6):1212-1223. PubMed ID: 35618837
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comparative proteomics in acute myeloid leukemia.
    Luczak M; Kaźmierczak M; Hadschuh L; Lewandowski K; Komarnicki M; Figlerowicz M
    Contemp Oncol (Pozn); 2012; 16(2):95-103. PubMed ID: 23788862
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Proteome activity landscapes of tumor cell lines determine drug responses.
    Frejno M; Meng C; Ruprecht B; Oellerich T; Scheich S; Kleigrewe K; Drecoll E; Samaras P; Hogrebe A; Helm D; Mergner J; Zecha J; Heinzlmeir S; Wilhelm M; Dorn J; Kvasnicka HM; Serve H; Weichert W; Kuster B
    Nat Commun; 2020 Jul; 11(1):3639. PubMed ID: 32686665
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Unlocking proteomic heterogeneity in complex diseases through visual analytics.
    Bhavnani SK; Dang B; Bellala G; Divekar R; Visweswaran S; Brasier AR; Kurosky A
    Proteomics; 2015 Apr; 15(8):1405-18. PubMed ID: 25684269
    [TBL] [Abstract][Full Text] [Related]  

  • 99. New considerations in the design of clinical trials for the treatment of acute leukemia.
    Hourigan CS; Karp JE
    Clin Investig (Lond); 2011 Apr; 1(4):509-517. PubMed ID: 23459118
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Optimizing Risk Stratification in Acute Myeloid Leukemia: Dynamic Models for a Dynamic Therapeutic Landscape.
    Short NJ; Tallman MS; Pollyea DA; Ravandi F; Kantarjian H
    J Clin Oncol; 2021 Aug; 39(23):2535-2538. PubMed ID: 34043455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.